NCT06451315 REGISTRY on the Implementation of Artificial Intelligence in the Automatic Analysis of Vascular Network Segmentation
| NCT ID | NCT06451315 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Abdominal Aortic Aneurysm |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-01-30 |
| Primary Completion | 2024-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2024-01-30 with a primary completion date of 2024-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The team hypothesizes that fully automatic analysis of AAA could provide increased performance (decreased duration of segmentation with increased reproducibility and decreased inter and intraobserver variability) to detect aortic aneurysmal sac enlargement (volumes and diameters) and predict the risk of complications during the procedure and during follow-up (MAE, MACE, MALE, Stroke) compared to standard methods of measurement relying on approximate maximum sac diameter.
Eligibility Criteria
Inclusion Criteria: * Male or female ≥18 years of age * AAA treated with EVAR between * ≥50mm * or ≥5mm increase in 6 months * The subject is legally competent, has been informed of the nature, the scope, and the relevance of the study and has not manifested an opposition to participate. * Available for set-up and proper implementation of follow-up visits (standard of care) throughout the duration of the registry Exclusion Criteria: * Advancing Alzheimer's disease or socially dependent patient * Opposition to the use of their data for this research * Life expectancy supposed to be inferior to 2 years * Pregnant woman
Contact & Investigator
Eric DUCASSE, MD, PhD
PRINCIPAL INVESTIGATOR
University Hospital, Bordeaux
Frequently Asked Questions
Who can join the NCT06451315 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Abdominal Aortic Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06451315 currently recruiting?
Yes, NCT06451315 is actively recruiting participants. Contact the research team at eric.ducasse@chu-bordeaux.fr for enrollment information.
Where is the NCT06451315 trial being conducted?
This trial is being conducted at Bordeaux, France.
Who is sponsoring the NCT06451315 clinical trial?
NCT06451315 is sponsored by University Hospital, Bordeaux. The principal investigator is Eric DUCASSE, MD, PhD at University Hospital, Bordeaux. The trial plans to enroll 250 participants.